Insmed Inc’s recent filing unveils that its Chief Medical Officer Flammer Martina M.D. unloaded Company’s shares for reported $0.39 million on Jan 10 ’25. In the deal valued at $63.64 per share,6,172 shares were sold. As a result of this transaction, Flammer Martina M.D. now holds 101,549 shares worth roughly $7.0 million.
Then, Flammer Martina M.D. sold 3,344 shares, generating $220,403 in total proceeds. Upon selling the shares at $65.91, the Chief Medical Officer now owns 102,766 shares.
Before that, Flammer Martina M.D. sold 1,702 shares. Insmed Inc shares valued at $112,604 were divested by the Chief Medical Officer at a price of $66.16 per share. As a result of the transaction, Flammer Martina M.D. now holds 101,064 shares, worth roughly $6.97 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Monday, Insmed Inc [NASDAQ:INSM] saw its stock jump 5.64% to $68.93. Over the last five days, the stock has lost -1.33%. Insmed Inc shares have fallen nearly -0.16% since the year began. Nevertheless, the stocks have risen 143.23% over the past one year. While a 52-week high of $80.53 was reached on 01/03/25, a 52-week low of $21.92 was recorded on 01/10/25. SMA at 50 days reached $71.11, while 200 days put it at $61.51.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 65.30, which if violated will result in even more drops to 61.68. On the upside, there is a resistance level at 70.98. A further resistance level may holdings at 73.04. The Relative Strength Index (RSI) on the 14-day chart is 47.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.16%. Stochastics %K at 40.01% indicates the stock is a holding.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2024-12-31, growing by 2.82 million shares to a total of 15.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 12.62 million shares. There was a rise of 18.29%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.